SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 65.86 |
| Enterprise Value ($M) | -51.00 |
| Book Value ($M) | 121.12 |
| Book Value / Share | 1.05 |
| Price / Book | 0.54 |
| NCAV ($M) | 121.12 |
| NCAV / Share | 1.05 |
| Price / NCAV | 0.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.77 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 86.78 |
| Current Ratio | 86.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 122.53 |
| Assets | 122.53 |
| Liabilities | 1.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Octagon Capital Advisors LP | 9.70 | ||
| 13G/A | Invus Global Management, LLC | 5.70 | ||
| 13G/A | Gilead Sciences Inc | 14.60 | 21.39 | |
| 13G/A | Fmr Llc | 4.99 | -19.21 | |
| 13G/A | Artal International S.C.A. | 5.80 | 18.29 | |
| 13G | EcoR1 Capital, LLC | 9.30 | ||
| 13G | Wilson John Robert | 8.98 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 54,930 | 278,631 | 19.71 | |
| 57,302 | 321,021 | 17.85 | |
| 205,147 | 643,227 | 31.89 | |
| 59,234 | 212,873 | 27.83 | |
| 163,358 | 360,628 | 45.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALDX – Aldeyra Therapeutics, Inc. | ALGS – Aligos Therapeutics, Inc. |
| ALRN – Aileron Therapeutics, Inc. | ALZN – Alzamend Neuro, Inc. |
| ANEB – Anebulo Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io